Correlation Between Belden and Aquestive Therapeutics

Can any of the company-specific risk be diversified away by investing in both Belden and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Belden and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Belden Inc and Aquestive Therapeutics, you can compare the effects of market volatilities on Belden and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Belden with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Belden and Aquestive Therapeutics.

Diversification Opportunities for Belden and Aquestive Therapeutics

0.67

Correlation Coefficient

Belden  Aquestive Therapeutics

Poor diversification

The 3 months correlation between Belden and Aquestive is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Belden Inc and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and Belden is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Belden Inc are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of Belden i.e., Belden and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between Belden and Aquestive Therapeutics

Considering the 90-day investment horizon Belden Inc is expected to under-perform the Aquestive Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Belden Inc is 2.44 times less risky than Aquestive Therapeutics. The stock trades about -0.09 of its potential returns per unit of risk. The Aquestive Therapeutics is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  359.00  in Aquestive Therapeutics on December 21, 2024 and sell it today you would lose (48.00) from holding Aquestive Therapeutics or give up 13.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.33%
Values	Daily Returns

Belden Inc  vs.  Aquestive Therapeutics

Belden Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Belden Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Aquestive Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aquestive Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Belden and Aquestive Therapeutics

The main advantage of trading using opposite Belden and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Belden position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.

The idea behind Belden Inc and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.